No Data
No Data
Aquestive Therapeutics: A Buy Rating on Underappreciated Market Potential and Innovative Pipeline
Express News | Aquestive Therapeutics Inc : Leerink Partners Raises Target Price to $10 From $8
Market Participants Recognise Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) Revenues Pushing Shares 37% Higher
Aquestive Therapeutics Outlines Growth and Product Progress
Express News | Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27TH
Express News | Aquestive Therapeutics Reiterates Expected Timing For Anaphylm NDA Filing For Q1 2025
No Data
No Data